(Q44387520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Klaus G Parhofer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ester Laubach

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

Journal of Lipid Research

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1192-1198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Newly Diagnosed Exercise-Induced Myocardial Ischemia in Middle-Aged Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

The effect of atorvastatin on postprandial lipaemia in overweight or obese women homozygous for apo E3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Effect of atorvastatin treatment on lipoprotein lipase mass in the pre-heparin plasma in Japanese hyperlipidemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Effect of treatment with a hydroxymethylglutaryl coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Cholesterol esters regulate apoB48 secretion in CaCo2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Postprandial lipoproteins and progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300011-JLR200

10.1194/JLR.M300011-JLR200

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12671031%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference